|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����ø�� |
|
Ƥ������ |
| ��������������� | |
|
���� |
|
�̺� |
| PubMed | |
|
Article by ���� |
|
Article by �̺� |
����øJNK��p38��Ƥ����
����1, �̺�2
1. �����е�һ����ҽԺƤ���� 310006;
2. �㽭��ѧ���ݷ�ҽԺƤ����
c-Jun����ĩ�˼�ø��p38��˿��ԭ�����øϸ���ź�ת��ͨ·����Ҫ�ĵ���ø��������ϸ�����Ӻ�Ӧ�������Ĵ̼���,�ɵ���c-Jun����ĩ�˼�øͨ·��p38ͨ·�ļ���,�������ı�ϸ��������ѧ���ԡ�����������c-Jun����ĩ�˼�ø��p38˿��ԭ�����øͨ·�ڶ���Ƥ�����и߶ȼ���,����ʾ�뷢��������һ������,�絥�����HIV��Ⱦ��HPV��Ⱦ�Լ�Ƥ�������ȡ�
1. �����е�һ����ҽԺƤ���� 310006;
2. �㽭��ѧ���ݷ�ҽԺƤ����
1. �����е�һ����ҽԺƤ���� 310006;
2. �㽭��ѧ���ݷ�ҽԺƤ����
[2] Papatsoris AG,Papavassiliou AG.Molecular 'palpation' of BPH:a tale of MAPK signalling? Trends Mol Med,2001,7(7):288-292.
[3] Li Z,Jiang Y,Ulevitch RJ,et al.The primary structure of p38 gamma:a new member of p38 group of MAP kinases.Biochem Biophys Res Commun,1996,228(2):334-340.
[4] Jiang Y,Chen C,Li Z,et al.Characterization of the structure and function of a new mitogen-activated protein kinase(p38beta).J Biol Chem,1996,271(30):17920-17926.
[5] Jiang Y,Gram H,Zhao M,et al.Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases,p38delta.J Biol Chem,1997,272(48):30122-30128.
[6] Seger R,Krebs EG.The MAPK signaling cascade.FASEB J,1995,9(9):726-735.
[7] Gupta S,Barrett T,Whitmarsh AJ,et al.Selective interaction of JNK protein kinase isoforms with transcription factors.EMBO J,1996,15(11):2760-2770.
[8] Whitmarsh AJ,Yang SH,Su MS,et al.Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors.Mol Cell Biol,1997,17(5):2360-2371.
[9] Chen YR,Tan TH.The c-Jun N-terminal kinase pathway and apoptotic signaling(review).Int J Oncol,2000,16(4):651-662.
[10] McLean TI,Bachenheimer SL.Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.J Virol,1999,73(10):8415-8426.
[11] Taher MM,Hershey CM,Oakley JD,et al.Role of the p38 and MEK-1/2/p42/44 MAP kinase pathways in the differential activation of human immunodeficiency virus gene expression by ultraviolet and ionizing radiation.Photochem Photobiol,2000,71(4):455-459.
[12] Murakami-Mori K,Mori S,Nakamura S.p38MAP kinase is a negative regulator for ERK1/2-mediated growth of AIDS-associated Kaposi's sarcoma cells.Biochem Biophys Res Commun,1999,264(3):676-682.
[13] Kan H,Xie Z,Finkel MS.HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation.Am J Physiol Heart Circ Physiol,2000,279(6):H3138-3143.
[14] Lannuzel A,Barnier JV,Hery C,et al.Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons.Ann Neurol,1997,42(6):847-856.
[15] Gu Y,Wu RF,Xu YC,et al.HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism.Virology,2001,286(1):62-71.
[16] Ruhland A,de Villiers EM.Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokines.Int J Cancer,2001,91(6):828-834.
[17] Crusius K,Rodriguez I,Alonso A.The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes.Virus Genes,2000,20(1):65-69.
[18] Bryan JT,Han A,Fife KH,et al.The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.Virology,2000,268(2):430-439.
[19] Gu Z,Matlashewski G.Effect of human papillomavirus type 16 oncogenes on MAP kinase activity.J Virol,1995,69(12):8051-8056.
[20] Milella M,Kornblau SM,Estrov Z,et al.Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.J Clin Invest,2001,108(6):851-859.
[21] Krause A,Holtmann H,Eickemeier S,et al.Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin(IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB.J Biol Chem,1998,273(37):23681-23689.
[22] Aguirre-Ghiso JA,Liu D,Mignatti A,et al.Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.Mol Biol Cell,2001,12(4):863-879.